dc.contributor.author | Saygı, Bacanak, M. | |
dc.contributor.author | Aydın, B. | |
dc.contributor.author | Cabadak, H. | |
dc.contributor.author | Nurten, A. | |
dc.contributor.author | Gören, M.Z. | |
dc.contributor.author | Enginar, N. | |
dc.date.accessioned | 2021-12-21T08:40:54Z | |
dc.date.available | 2021-12-21T08:40:54Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1664328 | |
dc.identifier.uri | https://doi.org/10.1016/j.bbr.2017.11.018 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1243 | |
dc.description.abstract | Treatment of fasted mice and rats with the nonselective muscarinic antagonist, scopolamine or atropine, causes convulsions after food intake. This study evaluated the effect of fasting on the expression of M 1 and M 2 muscarinic receptors in the brain reg | |
dc.description.sponsorship | This work was supported by Scientific Research Projects Coordination Unit of Istanbul University (project number: 46502). | |
dc.language.iso | English | |
dc.publisher | Elsevier B.V. | |
dc.title | Contribution of M 1 and M 2 muscarinic receptor subtypes to convulsions in fasted mice treated with scopolamine and given food | |
dc.type | Article | |
dc.relation.journal | Behavioural Brain Research | |
dc.identifier.startpage | 423 | |
dc.identifier.endpage | 430 | |
dc.identifier.volume | 364 | |
dc.identifier.doi | 10.1016/j.bbr.2017.11.018 | |
dc.relation.volume | 364 | |